NASDAQ:AMTXAemetis Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Aemetis Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.83 0.00 (0.00 %) (As of 07/10/2020 09:05 AM ET) Add Compare Share Today's Range$0.77Now: $0.83▼$0.8350-Day Range$0.76MA: $0.83▼$0.9452-Week Range$0.37Now: $0.83▼$1.72Volume296,900 shsAverage Volume153,735 shsMarket Capitalization$17.16 millionP/E RatioN/ADividend YieldN/ABeta0.57 ProfileAnalyst RatingsAdvanced ChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Aemetis, Inc. operates as a renewable fuels and bio-chemicals company in North America and India. The company focuses on the acquisition, development, and commercialization of various technologies that replace traditional petroleum-based products through the conversion of ethanol and biodiesel plants into advanced bio refineries. It owns and operates an ethanol plant in the California Central Valley near Modesto; and a biodiesel plant in Kakinada, India. The company sells biodiesel and refined glycerin to resellers, distributors, and refiners through its sales force and independent sales agents, as well as to brokers who resell the product to end-users. It also produces ethanol; and wet distiller's grains, distiller's corn oil, and condensed distillers solubles to dairies and feedlots as animal feed. The company was formerly known as AE Biofuels, Inc. and changed its name to Aemetis, Inc. in November 2011. Aemetis, Inc. was founded in 2005 and is headquartered in Cupertino, California.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Aemetis. Previous Next 2.4 Community Rank Outperform VotesAemetis has received 149 “outperform” votes. (Add your “outperform” vote.)Underperform VotesAemetis has received 167 “underperform” votes. (Add your “underperform” vote.)Community SentimentAemetis has received 52.85% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Aemetis and other stocks. Vote “Outperform” if you believe AMTX will outperform the S&P 500 over the long term. Vote “Underperform” if you believe AMTX will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldAemetis does not currently pay a dividend.Dividend GrowthAemetis does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Aemetis insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 28.02% of the stock of Aemetis is held by insiders.Percentage Held by InstitutionsOnly 7.17% of the stock of Aemetis is held by institutions. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Aemetis is -0.45, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Aemetis is -0.45, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.48 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Industrial organic chemicals Sub-IndustryN/A SectorOils/Energy Current SymbolNASDAQ:AMTX Previous Symbol CUSIPN/A CIK738214 Webwww.aemetis.com Phone408-517-3304Debt Debt-to-Equity RatioN/A Current Ratio0.16 Quick Ratio0.08Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$202 million Price / Sales0.08 Cash FlowN/A Price / Cash FlowN/A Book Value($7.50) per share Price / Book-0.11Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-35,720,000.00 Net Margins-19.06% Return on EquityN/A Return on Assets-32.43%Miscellaneous Employees152 Outstanding Shares20,680,000Market Cap$17.16 million Next Earnings Date8/13/2020 (Estimated) OptionableNot Optionable NASDAQ:AMTX Rates by TradingView Receive AMTX News and Ratings via Email Sign-up to receive the latest news and ratings for AMTX and its competitors with MarketBeat's FREE daily newsletter. Aemetis (NASDAQ:AMTX) Frequently Asked Questions How has Aemetis' stock been impacted by COVID-19 (Coronavirus)? Aemetis' stock was trading at $0.6511 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, AMTX stock has increased by 27.5% and is now trading at $0.83. View which stocks have been most impacted by Coronavirus. When is Aemetis' next earnings date? Aemetis is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020. View our earnings forecast for Aemetis. How were Aemetis' earnings last quarter? Aemetis Inc (NASDAQ:AMTX) posted its quarterly earnings data on Thursday, May, 14th. The specialty chemicals company reported ($0.58) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.34) by $0.24. The specialty chemicals company earned $39.48 million during the quarter. View Aemetis' earnings history. Has Aemetis been receiving favorable news coverage? Headlines about AMTX stock have been trending neutral recently, according to InfoTrie Sentiment. The research group ranks the sentiment of press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Aemetis earned a coverage optimism score of 0.5 on InfoTrie's scale. They also gave media coverage about the specialty chemicals company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View the latest news about Aemetis. Are investors shorting Aemetis? Aemetis saw a decrease in short interest in June. As of June 30th, there was short interest totaling 1,100 shares, a decrease of 95.5% from the June 15th total of 24,400 shares. Based on an average daily trading volume, of 843,300 shares, the days-to-cover ratio is currently 0.0 days. Currently, 0.0% of the company's stock are short sold. View Aemetis' Current Options Chain. Who are some of Aemetis' key competitors? Some companies that are related to Aemetis include Tantech (TANH), Pacific Ethanol (PEIX), CTD (CTDH), Sino United Worldwide Consolidated (SUIC), Wave Sync (WAYS), Gevo (GEVO), Pledge Petroleum (PROP), OriginClear (OCLN), Methes Energies International (MEIL) and Mission Newenergy (MNELF). View all competitors. What other stocks do shareholders of Aemetis own? Based on aggregate information from My MarketBeat watchlists, some companies that other Aemetis investors own include Amplify Energy (AMPY), Amplify Energy (AMPY), Pennsylvania R.E.I.T. (PEI), Tilly's (TLYS), AMC Entertainment (AMC), Chesapeake Energy (CHK), Great Panther Mining (GPL), Zosano Pharma (ZSAN), DHT (DHT) and Enerplus (ERF). Who are Aemetis' key executives? Aemetis' management team includes the following people: Mr. Eric A. McAfee, Co-Founder, Exec. Chairman, CEO & Pres (Age 56)Mr. Todd A. Waltz, Exec. VP, CFO & Sec. (Age 58)Mr. Andrew B. Foster, Exec. VP & COO (Age 54)Mr. Sanjeev Gupta, Exec. VP & MD, Chairman and Pres of Universal Biofuels Pvt. Ltd. (Age 59) What is Aemetis' stock symbol? Aemetis trades on the NASDAQ under the ticker symbol "AMTX." How do I buy shares of Aemetis? Shares of AMTX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Aemetis' stock price today? One share of AMTX stock can currently be purchased for approximately $0.83. How big of a company is Aemetis? Aemetis has a market capitalization of $17.16 million and generates $202 million in revenue each year. Aemetis employs 152 workers across the globe. What is Aemetis' official website? The official website for Aemetis is www.aemetis.com. How can I contact Aemetis? Aemetis' mailing address is 20400 STEVENS CREEK BLVD SUITE 700, CUPERTINO CA, 95014. The specialty chemicals company can be reached via phone at 408-517-3304 or via email at [email protected] This page was last updated on 7/10/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
